期刊文献+

乳腺肿物^(99m)Tc-MIBI显像、钼靶X线诊断对照分析 被引量:3

Control Study of ^(99m)Tc-MIBI imaging and mammography in the diagnosis of breast tumor
下载PDF
导出
摘要 目的 :分析比较99mTc -MIBI(甲氧基异丁基异腈)乳腺显像与钼靶X线摄影法对乳腺肿块的临床诊断价值。方法 :40例单侧乳腺肿块患者 ,包括良性病变29例 ,恶性病变11例 ,在1周内同时接受99mTc -MIBI乳腺显像和钼靶X线摄影检查。钼靶X线片结合放大镜观察钙化点的情况分析 ,99mTc -MIBI显像取感兴趣区(ROI) ,求出肿块与正常组织中放射性比值(T/NT)。结果 :99mTc-MIBI显像T/NT放射性比值 ,恶性为1 98±0 22(n=12) ;良性为1 16±0 10(n=28) ;两者有显著性差异(P<0 01)。99mTc-MIBI显像与钼靶X线摄影法诊断乳腺癌的灵敏度和特异性分别为83 3%、92 8%和90 9 %、24 1%。结论 :钼靶X线摄影发现乳腺恶性病变敏感性高而特异性低 ;99mTc-MIBI显像对乳腺肿块诊断特异性和准确性明显优于钼靶X线摄影 ,两种影像方法各有所长 ,如果结合应用 。 Objective:To evaluate the value of 99mTc-MIBI imaging and mammography in the diagnosis of breast tumor.Methods:99m Tc-MIBI imaging and mammography were performed within one week for 40 patients with palpable breast tumor(benign lesion 29,malignant lesion 11).The mammograms were read with calcifications observed under a magnifying glass.In 99mTc-MIBI imaging,region of interesting(ROI) was drawn and the ratio of radioactivity in tumor and nontumor tissue was calculated.Results:The ratio of T/NT was 1.98±0.22(n=12) in malignant tumor and 1.16±0.10(n=28) in benign lesion.There was significant difference by statistics (P<0.01).The sensitivity and specificity of 99mTc-MIBI imaging and mammography in the diagnosis of breast cancer were 83.3%,92.8%and 90.9%,24.1%,respectively.Conclusion:The mammography has higher sensitivity but lower specificity in the diagnosis of malignant tumor.99mTc-MIBI imaging has higher specificity.Both have their own advantages in the diagnosis of breast tumor.The accuracy of diagnosis will be improved with both methods.
出处 《中国临床医学影像杂志》 CAS 2000年第5期307-308,共2页 Journal of China Clinic Medical Imaging
关键词 乳腺肿瘤 放射性核素显像 乳房X线摄影术 诊断 breast neoplasms radionuclide imaging mammography
  • 相关文献

参考文献1

二级参考文献1

  • 1Israel Steiner,Oded Abramsky. Immunology of Guillain-Barré syndrome[J] 1985,Springer Seminars in Immunopathology(3):165~176

共引文献2

同被引文献20

  • 1乔新民,张嘉庆,周波,岳明纲,高伯山,齐桂英.^(99M)TC-MIBI乳腺肿物显像的初步临床应用[J].普外临床,1996,11(5):290-291. 被引量:5
  • 2Buscombe JR, Cwikla JB, Holloway B, et al. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves.J Nucl Med,2001,42(1) :3.
  • 3Meyer JE, Sonnenfeld MR, Greenes RA, et al. Preoperative localization of clinically occult breast lesions : experience at a referral hospital. Radiology, 1988,169(3) : 627.
  • 4Sickles EA. Mammographic features of 300 consecutive nonpalpable breast cancers. Am J Roentgenol, 1986,146(4) :661.
  • 5Jackson VP, Hendrick RE, Kerg SA, et al. Imaging of the radiographically dense breast. Radiology, 1993,188(2) : 297.
  • 6Del Vecchio S, Ciarmiello A, Potena MI, et al. In vivo detection of multidrug-resistant ( MDR1 ) phenotype by technetium-99m sestimibi scan in untreated breast cancer patients.Eur J Nucl Med,1997,24(2):150.
  • 7Kopans DB. The positive predictive value of mammography[J]. AJR, 1992, 158(3): 521-526.
  • 8Bird RE, Wallace TW, Yankaskas BC. Analysis of cancer missed at screening mammography[J]. Radiology, 1992, 184(3): 613-617.
  • 9Nilott PM, Sheiner NM. False negative mammograms in patients with breast cancer[J]. Can J Surg, 1981, 24: 50-52.
  • 10Taillefer R. The role of 99Tcm-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis [J]. Semin Nucl Med, 1999, 29: 16-40.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部